Time to strengthen the evidence base for paediatric formulations

[1]  I. Choonara,et al.  Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study , 1999, Acta paediatrica.

[2]  Jörg Breitkreutz,et al.  Paediatric and geriatric drug delivery , 2007, Expert opinion on drug delivery.

[3]  S. Conroy,et al.  Unlicensed and off label drug use in neonates , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[4]  H Corns,et al.  Unlicensed and off label prescribing of drugs in general practice , 2000, Archives of disease in childhood.

[5]  Susan M Abdel-Rahman,et al.  Developmental pharmacology--drug disposition, action, and therapy in infants and children. , 2003, The New England journal of medicine.

[6]  T. J. Cook,et al.  Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. , 2004, Journal of the American Pharmacists Association : JAPhA.

[7]  I. Wong,et al.  Supply problems of unlicensed and off-label medicines after discharge , 2006, Archives of Disease in Childhood.

[8]  T. Stephenson.  How children's responses to drugs differ from adults. , 2005, British journal of clinical pharmacology.